Insider Buying

ONCOLYTICS BIOTECH INC (ONCY) Insider Buying

Every C-suite and executive open-market purchase of ONCOLYTICS BIOTECH INC stock we've tracked from SEC Form 4 filings — each scored on our six-factor model. Not financial advice.

Tracked buys
3
Total value
$44,473
Most recent
Mar 12, 2026
Ticker Insider Role Value Filed Signal Score
ONCY ONCOLYTICS BIOTECH INC Kelly Jared Chief Executive Officer $4,848 Mar 13, 2026 WATCH 45
ONCY ONCOLYTICS BIOTECH INC Look Kirk Chief Financial Officer $10,104 Feb 13, 2026 WATCH 48
ONCY ONCOLYTICS BIOTECH INC Kelly Jared Chief Executive Officer $29,521 Feb 13, 2026 WATCH 46

What this page tracks

This is a live record of open-market stock purchases by directors and officers of ONCOLYTICS BIOTECH INC, sourced directly from SEC EDGAR Form 4 filings. We only count open-market buys — not option exercises or grants — because a personal-money purchase is the cleanest insider conviction signal.

Each filing is scored with our six-factor methodology (fundamentals, financials, technicals, conviction, CEO history, and cluster activity). See how the resulting signals performed against the S&P 500 on the track record, or browse this week's insider buys and the full signal screener.

Not financial advice. For educational purposes only. Form 4 data can be amended or filed late; analysis is generated using AI and may contain errors. Always do your own due diligence.

Get new ONCY signals the morning they file

One email a day with newly scored CEO insider-buying signals. $3.99/mo, cancel anytime.

Start Free 7-Day Trial